Dogmatil Sulpiride is an antipsychotic medication belonging to the benzamide class. It acts as a selective dopamine D2 and D3 receptor antagonist, exerting its therapeutic effects through modulation of dopaminergic neurotransmission. Dogmatil Sulpiride is indicated for the management of various psychiatric disorders, including schizophrenia, depressive disorders, and anxiety. It is also used in the treatment of psychosomatic disorders and as an adjunct therapy in alcohol withdrawal. The medication has been shown to improve symptoms such as hallucinations, delusions, and emotional disturbances in patients with schizophrenia. Dogmatil Sulpiride may help enhance mood and reduce anxiety in individuals with depressive disorders. Additionally, it can aid in managing somatic symptoms associated with psychological distress.